Cargando…
Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection
An assay employing a panel of tumor-associated antigens has been validated and is available commercially (EarlyCDT®-Lung) to aid the early detection of lung cancer by measurement of serum autoantibodies. The high throughput (HTP) strategy described herein was pursued to identify new antigens to add...
Autores principales: | Macdonald, Isabel K., Allen, Jared, Murray, Andrea, Parsy-Kowalska, Celine B., Healey, Graham F., Chapman, Caroline J., Sewell, Herbert F., Robertson, John F. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399887/ https://www.ncbi.nlm.nih.gov/pubmed/22815807 http://dx.doi.org/10.1371/journal.pone.0040759 |
Ejemplares similares
-
Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT(®)-Lung Test
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma
por: Welberry, Christopher, et al.
Publicado: (2020) -
Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
por: Middleton, Catrin H., et al.
Publicado: (2014) -
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
por: Chapman, Caroline J., et al.
Publicado: (2012) -
Technical validation of an autoantibody test for lung cancer
por: Murray, A., et al.
Publicado: (2010)